Applecross, Australia

Steve D Wilton

This inventor holds 2 USPTO granted patents. Top assignee: Vision Pharma Pty Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steve D Wilton. Retrieved from https://idiyas.com/inventor/steve-d-wilton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Steve D Wilton: Innovator in Retinitis Pigmentosa Treatment

Introduction

Steve D Wilton is a prominent inventor based in Applecross, Australia. He has made significant contributions to the field of medical treatments, particularly focusing on innovative solutions for Retinitis Pigmentosa. With a total of 2 patents to his name, Wilton is recognized for his dedication to advancing healthcare through his inventions.

Latest Patents

One of Wilton's latest patents is a Novel Retinitis Pigmentosa Treatment. This groundbreaking work aims to provide new hope for individuals affected by this degenerative eye disease. His research and development efforts are paving the way for more effective therapies in the field of ophthalmology.

Career Highlights

Wilton is currently associated with Vision Pharma Pty Ltd, where he continues to work on innovative treatments. His career is marked by a commitment to improving patient outcomes through scientific research and technological advancements. His contributions have been instrumental in the development of new therapeutic approaches.

Collaborations

Steve D Wilton has collaborated with notable colleagues, including Sue Fletcher and Fred K Chen. These partnerships have enhanced his research efforts and contributed to the success of his projects.

Conclusion

Steve D Wilton is a dedicated inventor whose work in Retinitis Pigmentosa treatment exemplifies innovation in healthcare. His contributions are vital in the ongoing quest for effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…